This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
KCI Medical Holding GmbH
KCI Medical Holding GmbH, commonly referred to as KCI, is a prominent player in the medical technology industry, headquartered in Germany. Founded in 1990, the company has established itself as a leader in advanced wound care and regenerative medicine, with a strong operational presence across Europe and North America. KCI is renowned for its innovative products, including negative pressure wound therapy (NPWT) systems, which are designed to enhance healing and improve patient outcomes. The company’s commitment to research and development has led to significant advancements in wound management, setting it apart from competitors. With a solid market position, KCI Medical Holding GmbH has received numerous accolades for its contributions to healthcare, making it a trusted name among healthcare professionals and patients alike.
DitchCarbon Score
How does KCI Medical Holding GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
KCI Medical Holding GmbH's score of 58 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
KCI Medical Holding GmbH, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Solventum Corporation, which may influence its climate commitments and performance metrics. As a subsidiary, KCI Medical Holding GmbH's climate initiatives and reduction targets are likely aligned with those of Solventum Corporation. However, no specific reduction targets or climate pledges have been disclosed for KCI Medical Holding GmbH itself. The lack of detailed emissions data and reduction initiatives suggests that the company may still be in the early stages of formalising its climate strategy. In the context of the industry, it is essential for companies like KCI Medical Holding GmbH to establish clear carbon reduction commitments and report emissions transparently to meet growing stakeholder expectations and regulatory requirements.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 157,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 111,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 2,229,960,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
KCI Medical Holding GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
